| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/22/1999 | CN1047534C Scar-eliminating scald ointment |
| 12/22/1999 | CN1047527C Chinese herb medicine instant granule for preventing and curing cardiovascular and cerebrovascular diseases |
| 12/22/1999 | CN1047522C Method for refining aqueous extract of traditional Chinese medicine |
| 12/22/1999 | CN1047518C Method of preparing oral pharmaceutical compositions |
| 12/21/1999 | US6005039 Composite pressure sensitive hydrophilic adhesive and method of preparing the same |
| 12/21/1999 | US6005020 Bioresorbable compositions for implantable prostheses |
| 12/21/1999 | US6005005 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl) propionic acid |
| 12/21/1999 | US6005001 Pharmaceutical composition |
| 12/21/1999 | US6004996 Tetrahydrolipstatin containing compositions |
| 12/21/1999 | US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates |
| 12/21/1999 | US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy |
| 12/21/1999 | US6004949 Aqueous composition containing cromoglycic acid |
| 12/21/1999 | US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis |
| 12/21/1999 | US6004763 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 12/21/1999 | US6004585 Granular composition of a triazine compound |
| 12/21/1999 | US6004582 For immediate delivery of a first active agent followed by a monitored, continuous, controlled and/or retarded delivery of a second active agent which is the same or different as the first active agent; time-release agents |
| 12/21/1999 | US6004581 Modified release oral pharmaceutical composition and method for the treatment of bowel diseases |
| 12/21/1999 | US6004580 Comprising hydrophilic component, lipophilic component, surfactant, drug; drug immobilized in microemulsion-based gel |
| 12/21/1999 | US6004579 Aging inhibition; wound healing agent; preserving organs; treating dermatological conditions such as wrinkling, sagging, baldness, psoriasis |
| 12/21/1999 | US6004578 For enhancing the percutaneous absorption of drugs when administered to a body surface or membrane |
| 12/21/1999 | US6004577 Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions |
| 12/21/1999 | US6004575 Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability |
| 12/21/1999 | US6004574 For administration of medically useful polypeptides, for administering polypeptides through inhalation |
| 12/21/1999 | US6004573 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 12/21/1999 | US6004566 Bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion |
| 12/21/1999 | US6004551 Lactobacillus, skim milk, lactobacillus growth factor (lgf) and lactobacillus compositions which adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents |
| 12/21/1999 | US6004549 Crystalline protein controlled release compositions |
| 12/21/1999 | US6004537 Inhaler comprising container of pressurized aerosol solution comprising budesonide, formoterol, fluoroalkane propellant, cosolvent present in amount to dissolve or solubilize mixture |
| 12/21/1999 | US6004534 Polymerized liposomes which have been modified, preferably on their surface, to contain molecule or ligand which targets specific site |
| 12/21/1999 | US6004299 Injection vessel and solution-enclosed injection vessel in use thereof |
| 12/21/1999 | CA2197075C Method of gene therapy using dna vectors without selection marker gene |
| 12/21/1999 | CA2148311C Lipid vesicles, their process of production and their applications |
| 12/21/1999 | CA2147272C Convertible microemulsion formulations |
| 12/21/1999 | CA2126441C Microcrystalline cellulose spheronization composition |
| 12/21/1999 | CA2124425C Pharmaceutical tablets releasing the active substance after a definite period of time |
| 12/21/1999 | CA2082951C Pulmonary administration of granulocyte colony stimulating factor |
| 12/21/1999 | CA2001325C Stabile parenteral solution of 2-phenyl-1,2-benzisoselenazol-3(2h)-one and process for producing the same |
| 12/16/1999 | WO1999065136A1 Chuck apparatus for clamping a planar substrate in an electrostatic coating method |
| 12/16/1999 | WO1999064615A1 Formulations for electroporation |
| 12/16/1999 | WO1999064598A2 Novel insulin analogs with enhanced zinc binding |
| 12/16/1999 | WO1999064580A1 Microneedle devices and methods of manufacture and use thereof |
| 12/16/1999 | WO1999064465A1 Diluting and disintegrating composition, method for obtaining same and use thereof |
| 12/16/1999 | WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions |
| 12/16/1999 | WO1999064393A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 12/16/1999 | WO1999064094A1 Methods of delivering aerosolized polynucleotides to the respiratory tract |
| 12/16/1999 | WO1999064082A1 Plaster containing an active agent |
| 12/16/1999 | WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders |
| 12/16/1999 | WO1999064050A1 Novel potassium channel drugs and their uses |
| 12/16/1999 | WO1999064027A1 Extracts of hypericum perforatum and formulations containing them |
| 12/16/1999 | WO1999064026A1 A process of powder for bath from natural plants |
| 12/16/1999 | WO1999064014A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 12/16/1999 | WO1999063997A1 Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines |
| 12/16/1999 | WO1999063986A1 Formulations for the treatment of gastro-oesophageal reflux |
| 12/16/1999 | WO1999063972A1 Pharmaceutical product and methods and apparatus for making same |
| 12/16/1999 | WO1999063971A1 Micro-osmotic controlled drug delivery systems |
| 12/16/1999 | WO1999063970A1 Delavirdine tablet formulation |
| 12/16/1999 | WO1999063969A1 Stabilized thyroxine medications |
| 12/16/1999 | WO1999063968A1 Aqueous preparations containing hardly soluble drug |
| 12/16/1999 | WO1999063967A1 Enhanced intra vaginal devices |
| 12/16/1999 | WO1999063951A1 Gel cosmetic compositions |
| 12/16/1999 | WO1999063828A1 Broad specificity dna damage endonuclease |
| 12/16/1999 | WO1999055286A9 Drug-containing transdermal patches, plastisols and adhesives |
| 12/16/1999 | DE19826592A1 Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats A process for producing a laminate comprising individual layers |
| 12/16/1999 | DE19826503A1 Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden Cosmetic and dermatological preparations containing chitosan and phospholipids |
| 12/16/1999 | DE19826213A1 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New antiestrogens, processes for their preparation and their pharmaceutical use |
| 12/16/1999 | DE19826118A1 Wasserhaltige kosmetische oder pharmazeutische Stifte Hydrous cosmetic or pharmaceutical sticks |
| 12/16/1999 | DE19825856A1 New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion |
| 12/16/1999 | CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 12/16/1999 | CA2334625A1 Extracts of hypericum perforatum and formulations containing them |
| 12/16/1999 | CA2334531A1 Gel cosmetic compositions |
| 12/16/1999 | CA2334296A1 Enhanced intra vaginal devices |
| 12/16/1999 | CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders |
| 12/16/1999 | CA2333116A1 Chuck apparatus for clamping a planar substrate in an electrostatic coating method |
| 12/16/1999 | CA2333107A1 Pharmaceutical product and methods and apparatus for making same |
| 12/16/1999 | CA2330211A1 Formulations for electroporation |
| 12/16/1999 | CA2318745A1 Novel potassium channel drugs and their uses |
| 12/16/1999 | CA2301042A1 Micro-osmotic controlled drug delivery systems |
| 12/15/1999 | EP0964000A1 Excipient and disintegrant composition, process for obtaining the same and its use |
| 12/15/1999 | EP0963486A1 Composition containing humidity regulators, for tissue products |
| 12/15/1999 | EP0963202A1 Formulations and methods for providing prolonged local anesthesia |
| 12/15/1999 | EP0963198A1 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 12/15/1999 | EP0963196A2 Hyaluronic drug delivery system |
| 12/15/1999 | EP0963161A1 Sugar-free dragee chewing sweets |
| 12/15/1999 | EP0806894A4 Micellar nanoparticles |
| 12/15/1999 | EP0805676B1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules |
| 12/15/1999 | EP0701704B1 Material to be worn on the eyeball |
| 12/15/1999 | EP0685457B1 Glycerol derivative, device and pharmaceutical composition |
| 12/15/1999 | EP0650354B1 Solid and liquid solutions of drugs which are not readily soluble in water |
| 12/15/1999 | EP0648106B1 Use of a vinyl lactam derived terpolymer as foaming agent in aerosol foam-forming compositions, and composition thereby obtained |
| 12/15/1999 | EP0587840B1 Bioartificial endocrine device |
| 12/15/1999 | EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug |
| 12/15/1999 | CN2353377Y Glossy-ganoderm instant powder packed in bag |
| 12/15/1999 | CN1238700A Improvents in or relating to diagnostic/therapeutic agents |
| 12/15/1999 | CN1238699A Improvements in or relating to contrast agents |
| 12/15/1999 | CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 12/15/1999 | CN1238695A Topical composition for preventing or treating bacterial skin infections |
| 12/15/1999 | CN1238691A Liquid alendronate preparation |
| 12/15/1999 | CN1238690A Improved pharmaceutical compositions |
| 12/15/1999 | CN1238687A An oil composition of dihydropolyprenols |
| 12/15/1999 | CN1238211A Yexiazhu tablet for treating hepatism |